Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jan 7, 2024; 30(1): 9-16
Published online Jan 7, 2024. doi: 10.3748/wjg.v30.i1.9
2023: A year of accomplishments for the 13 Science Citation Index Expanded- and Emerging Sources Citation Index-indexed Baishideng journals
Jin-Lei Wang, Jia-Ping Yan, Jia-Ru Fan, Xiang Li, Xu Guo, Jia-Wei Li, Yun-Xiaojian Wu, Jing-Jie Wang, Yu-Lu Chen, Li Li, Cong Lin, Xin-Liang Qu, Ji-Hong Liu, Yan-Liang Zhang, Ying-Yi Yuan, Hua-Ge Yu, Yu-Xi Chen, Yi-Xuan Cai, Xiang-Di Zhang, Si Zhao, Zi-Hang Xu, Li Ma, Na Ma, Diao-Mei Guo, Lian-Sheng Ma
Jin-Lei Wang, Jia-Ping Yan, Jia-Ru Fan, Xiang Li, Xu Guo, Jia-Wei Li, Yun-Xiaojian Wu, Jing-Jie Wang, Yu-Lu Chen, Li Li, Cong Lin, Xin-Liang Qu, Ji-Hong Liu, Yan-Liang Zhang, Ying-Yi Yuan, Hua-Ge Yu, Yu-Xi Chen, Yi-Xuan Cai, Xiang-Di Zhang, Si Zhao, Zi-Hang Xu, Li Ma, Na Ma, Diao-Mei Guo, Lian-Sheng Ma, Baishideng Publishing Group Inc, Pleasanton, CA 94566, United States
Author contributions: Ma LS conceptualized and designed the study; Wang JL organized the study materials, performed the data collection and analysis, and wrote the first draft of the manuscript; All authors reviewed the manuscript, and read and approved the final manuscript.
Conflict-of-interest statement: There is no conflict-of-interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Lian-Sheng Ma, Founder and CEO, Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, United States. l.s.ma@baishideng.com
Received: December 25, 2023
Peer-review started: December 25, 2023
First decision: December 27, 2023
Revised: January 2, 2024
Accepted: January 2, 2024
Article in press: January 2, 2024
Published online: January 7, 2024
Abstract

In 2023, Baishideng Publishing Group (Baishideng) routinely published 47 open-access journals, including 46 English-language journals and 1 Chinese-language journal. Our successes were accomplished through the collective dedicated efforts of Baishideng staffs, Editorial Board Members, and Peer Reviewers. Among these 47 Baishideng journals, 7 are included in the Science Citation Index Expanded (SCIE) and 6 in the Emerging Sources Citation Index (ESCI). With the support of Baishideng authors, company staffs, Editorial Board Members, and Peer Reviewers, the publication work of 2023 is about to be successfully completed. This editorial summarizes the 2023 activities and accomplishments of the 13 SCIE- and ESCI-indexed Baishideng journals, outlines the Baishideng publishing policy changes and additions made this year, and highlights the unique advantages of Baishideng journals.

Keywords: Baishideng Publishing Group, Journal Impact Factor, Open access, Policy changes, Policy additions, Unique advantages, Anxiety disorders, Colorectal cancer, Inflammatory bowel disease, Hepatocellular carcinoma, Gut microbes, Atrial fibrillation

Core Tip: With the support of Baishideng Publishing Group (Baishideng) authors, company staffs, Editorial Board Members, and Peer Reviewers, the publication work of our 47 open-access journals in 2023 is about to be successfully completed. This editorial summarizes the 2023 activities and accomplishments of the 13 Baishideng journals indexed in Science Citation Index Expanded and Emerging Sources Citation Index, outlines the Baishideng publishing policy changes and additions made this year, and highlights the unique advantages of Baishideng journals.